Jan Frenking, Christine Riedhammer, Britta Besemer, Jan Braune, Annamaria Brioli, Franziska Brunner, Maria Dampmann, Deniz Gezer, Sarah Goldman-Mazur, Mathias Hänel, Christine Hanoun, Marion Högner, Katja Kolditz, Igor Kos, Miriam Kull, Theo Leitner, Maximilan Merz, Ivana von Metzler, Christian S. Michel, Raphael Teipel, Marc-Steffen Raab
{"title":"P-021 A German Multicenter Real-World Analysis of Talquetamab in 102 Patients With Relapsed/Refractory Multiple Myeloma","authors":"Jan Frenking, Christine Riedhammer, Britta Besemer, Jan Braune, Annamaria Brioli, Franziska Brunner, Maria Dampmann, Deniz Gezer, Sarah Goldman-Mazur, Mathias Hänel, Christine Hanoun, Marion Högner, Katja Kolditz, Igor Kos, Miriam Kull, Theo Leitner, Maximilan Merz, Ivana von Metzler, Christian S. Michel, Raphael Teipel, Marc-Steffen Raab","doi":"10.1016/S2152-2650(24)01924-4","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S52-S53"},"PeriodicalIF":2.7000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma, Myeloma & Leukemia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2152265024019244","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
期刊介绍:
Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.